Vincent Marconi
Vincent Marconi
Professor of Medicine, Emory University
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Code saturation versus meaning saturation: how many interviews are enough?
MM Hennink, BN Kaiser, VC Marconi
Qualitative health research 27 (4), 591-608, 2017
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
International HIV Controllers Study
Science 330 (6010), 1551-1557, 2010
Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study
N Crum-Cianflone, KH Hullsiek, V Marconi, A Weintrob, A Ganesan, ...
AIDS (London, England) 23 (1), 41, 2009
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study
JF Okulicz, VC Marconi, ML Landrum, S Wegner, A Weintrob, A Ganesan, ...
The Journal of infectious diseases 200 (11), 1714-1723, 2009
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa
VC Marconi, H Sunpath, Z Lu, M Gordon, K Koranteng-Apeagyei, ...
Clinical infectious diseases 46 (10), 1589-1597, 2008
Anal cancers among HIV-infected persons: HAART is not slowing rising incidence
NF Crum-Cianflone, KH Hullsiek, VC Marconi, A Ganesan, A Weintrob, ...
AIDS (London, England) 24 (4), 535, 2010
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility
W He, S Neil, H Kulkarni, E Wright, BK Agan, VC Marconi, MJ Dolan, ...
Cell host & microbe 4 (1), 52-62, 2008
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms
MJ Dolan, H Kulkarni, JF Camargo, W He, A Smith, JM Anaya, T Miura, ...
Nature immunology 8 (12), 1324-1336, 2007
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
J B Nachega, V C Marconi, G U van Zyl, E M Gardner, W Preiser, ...
Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2011
Increasing rates of obesity among HIV-infected persons during the HIV epidemic
N Crum-Cianflone, MP Roediger, L Eberly, M Headd, V Marconi, ...
Plos one 5 (4), e10106, 2010
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ...
The Lancet infectious diseases 16 (5), 565-575, 2016
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression
TD Burt, BK Agan, VC Marconi, W He, H Kulkarni, JE Mold, M Cavrois, ...
Proceedings of the National Academy of Sciences 105 (25), 8718-8723, 2008
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States
CS Kraft, AL Hewlett, S Koepsell, AM Winkler, CJ Kratochvil, LA Larson, ...
Clinical infectious diseases 61 (4), 496-502, 2015
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals
SK Ahuja, H Kulkarni, G Catano, BK Agan, JF Camargo, W He, ...
Nature medicine 14 (4), 413-420, 2008
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007
JE Tate, ML Bunning, L Lott, X Lu, J Su, D Metzgar, L Brosch, CA Panozzo, ...
The Journal of infectious diseases 199 (10), 1419-1426, 2009
Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care
PG Farnham, C Gopalappa, SL Sansom, AB Hutchinson, JT Brooks, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (2), 183-189, 2013
Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States
AM Liddell, RT Davey Jr, AK Mehta, JB Varkey, CS Kraft, GK Tseggay, ...
Annals of internal medicine 163 (2), 81-90, 2015
In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine
R Paredes, M Sagar, VC Marconi, R Hoh, JN Martin, NT Parkin, ...
Journal of virology 83 (4), 2038-2043, 2009
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen
H Sunpath, B Wu, M Gordon, J Hampton, B Johnson, MYS Moosa, ...
Aids 26 (13), 1679-1684, 2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20